Healthcare
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Eli Lilly
LLY
$1.03T
| $1.03T | $1,152.93 | 0.04% |
|
| 2 |
2
Johnson & Johnson
JNJ
$651B
| $651B | $269.99 | 0.09% |
|
| 3 |
3
AbbVie
ABBV
$466B
| $466B | $263.96 | 0.02% |
|
| 4 |
4
Merck
MRK
$362B
| $362B | $146.87 | 0.19% |
|
| 5 |
5
UnitedHealth
UNH
$338B
| $338B | $376.90 | 0.45% |
|
| 6 |
6
Novartis
NVS
$267B
| $267B | $140.37 | 0.39% |
|
| 7 |
7
AstraZeneca
AZN
$258B
| $258B | $166.08 | 0.04% |
|
| 8 |
8
Thermo Fisher Scientific
TMO
$241B
| $241B | $651.45 | 1.04% |
|
| 9 |
9
Amgen
AMGN
$208B
| $208B | $385.65 | 1.55% |
|
| 10 |
NVO
10
Novo Nordisk
NVO
$191B
| $191B | $43.24 | 0.12% |
|
| 11 |
11
Gilead Sciences
GILD
$186B
| $186B | $150.11 | 0.52% |
|
| 12 |
12
Abbott
ABT
$178B
| $178B | $102.61 | 0.37% |
|
| 13 |
13
Pfizer
PFE
$158B
| $158B | $27.66 | 0.07% |
|
| 14 |
14
Danaher
DHR
$149B
| $149B | $211.81 | 0.32% |
|
| 15 |
15
Intuitive Surgical
ISRG
$139B
| $139B | $393.33 | 2.55% |
|
| 16 |
16
Vertex Pharmaceuticals
VRTX
$129B
| $129B | $508.34 | 1.55% |
|
| 17 |
17
Bristol-Myers Squibb
BMY
$129B
| $129B | $63.06 | 0.35% |
|
| 18 |
18
Medtronic
MDT
$118B
| $118B | $92.13 | 0.69% |
|
| 19 |
19
CVS Health
CVS
$114B
| $114B | $88.84 | 1.58% |
|
| 20 |
20
Stryker
SYK
$106B
| $106B | $275.12 | 1.79% |
|
| 21 |
21
McKesson
MCK
$102B
| $102B | $874.65 | 0.56% |
|
| 22 |
22
Sanofi
SNY
$102B
| $102B | $42.48 | 1.53% |
|
| 23 |
23
GSK
GSK
$101B
| $101B | $50.22 | 1.65% |
|
| 24 |
24
HCA Healthcare
HCA
$92.6B
| $92.6B | $427.71 | 0.31% |
|
| 25 |
25
Elevance Health
ELV
$89.1B
| $89.1B | $410.95 | 0.8% |
|
Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 1,119 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $9.3T.
The largest by market cap are Eli Lilly (LLY) at $1.03T, Johnson & Johnson (JNJ) at $651B and AbbVie (ABBV) at $466B.
Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 527 funds opened new positions, taking total fund holders up 337 (11%) quarter-over-quarter.
- Combined market cap: $9.3T across 1,119 stocks.
- Largest constituent: Eli Lilly (LLY), $1.03T market cap.
- Most net new fund positions in Q2 2026: UnitedHealth (UNH), +337 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.